Search Results - "Hain, S. F."

Refine Results
  1. 1

    FDG-PET. A possible prognostic factor in head and neck cancer by HALFPENNY, W, HAIN, S. F, BIASSONI, L, MAISEY, M. N, SHERMAN, J. A, MCGURK, M

    Published in British journal of cancer (12-02-2002)
    “…Previous studies have shown that high uptake of (18)F-fluoro-2-deoxy-glucose in head and neck cancer, as determined by the standardized uptake value on…”
    Get full text
    Journal Article
  2. 2

    2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: Influence on patient management in a single institution by Partridge, S., Timothy, A., O'Doherty, M. J., Hain, S. F., Rankin, S., Mikhaeel, G.

    Published in Annals of oncology (01-10-2000)
    “…Purpose: Optimum therapy for patients with Hodgkin's disease (HD) is determined by a number of prognostic factors, one of which is an accurate definition of…”
    Get full text
    Journal Article
  3. 3

    The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders by Rees, J. H., Hain, S. F., Johnson, M. R., Hughes, R. A. C., Costa, D. C., Ell, P. J., Keir, G., Rudge, P.

    Published in Brain (London, England : 1878) (01-11-2001)
    “…The detection of an occult tumour in a patient with a suspected paraneoplastic neurological disorder (PND) may be difficult because of the limitations of…”
    Get full text
    Journal Article
  4. 4

    Positron emission tomography for urological tumours by Hain, S.F., Maisey, M.N.

    Published in BJU international (01-07-2003)
    “…SUMMARY For urological tumours, positron emission tomography (PET) is currently most useful in testicular cancer. In patients with residual masses or raised…”
    Get full text
    Journal Article
  5. 5

    Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse by HAIN, S. F, O'DOHERTY, M. J, TIMOTHY, A. R, LESLIE, M. D, HARPER, P. G, HUDDART, R. A

    Published in British journal of cancer (01-10-2000)
    “…Differentiation of active disease from fibrosis/mature teratoma in patients with residual masses or identifying of sites of recurrence in patients with raised…”
    Get full text
    Journal Article
  6. 6
  7. 7

    18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas by MIKHAEEL, N. G, TIMOTHY, A. R, HAIN, S. F, O'DOHERTY, M. J

    Published in Annals of oncology (2000)
    “…The problem of residual masses on post-treatment CT scans is a continuing dilemma for the oncologist treating malignant lymphomas. These masses may contain…”
    Get full text
    Conference Proceeding Journal Article
  8. 8

    Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours? by HAIN, S F, OʼDOHERTY, M J, BINGHAM, J, CHINYAMA, C, SMITH, M A

    Published in Nuclear medicine communications (01-11-2003)
    “…Magnetic resonance imaging (MRI) has been the most useful tool in the anatomical definition of soft tissue sarcoma, although there remains the problem of…”
    Get full text
    Journal Article
  9. 9

    Primary diffuse leptomeningeal gliomatosis simulating tuberculous meningitis by Rees, J H, Balakas, N, Agathonikou, A, Hain, S F, Giovanonni, G, Panayiotopoulos, C P, Luxsuwong, M, Revesz, T

    “…Three patients are reported on who presented with communicating hydrocephalus due to presumed tuberculous meningitis. Subsequent clinical deterioration despite…”
    Get full text
    Journal Article
  10. 10

    FDG-PET as a metabolic biopsy tool in non-lung lesions with indeterminate biopsy by BEGGS, A. D, HAIN, S. F, CURRAN, K. M, O'DOHERTY, M. J

    Published in European journal of nuclear medicine (01-04-2002)
    “…The differentiation of benign versus malignant disease in a lesion identified on conventional imaging is a commonly encountered problem. Attempted biopsy is…”
    Get full text
    Journal Article
  11. 11

    Recent advances in imaging hepatocellular carcinoma: diagnosis, staging and response assessment: functional imaging by Hain, S F, Fogelman, I

    Published in The cancer journal (Sudbury, Mass.) (01-03-2004)
    “…Historically, nuclear medicine has had an important role in the differential diagnosis of liver tumors but has been largely superseded by other forms of…”
    Get full text
    Journal Article
  12. 12

    FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy by Hain, S F, Curran, K M, Beggs, A D, Fogelman, I, O'Doherty, M J, Maisey, M N

    Published in European Journal of Nuclear Medicine (01-09-2001)
    “…A common problem encountered in clinical medicine is the classification of a lung lesion (nodule/opacity) on conventional imaging. Often attempts at biopsy are…”
    Get full text
    Journal Article
  13. 13

    Positron emission tomography (PET) in the management of oro-pharyngeal cancer by Jones, J., Farag, I., Hain, S.F., McGurk, M.

    Published in European journal of surgical oncology (01-03-2005)
    “…To investigate the specific role of FDG–PET in the management of head and neck cancer patients. In a retrospective study, 112 patients with head and neck…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Can upright myocardial perfusion imaging be used alone with a solid-state dedicated cardiac camera? by Hain, S F, Van Gramberg, D, Bomanji, J B, Kayani, I, Groves, A M, Ben-Haim, S

    “…The novel solid state dedicated cardiac cameras provide fast high resolution cardiac imaging. The D-SPECT camera enables semi-reclining (upright) positioning,…”
    Get full text
    Journal Article
  16. 16

    Positron emission tomography in uro-oncology by Hain, S F

    Published in Cancer imaging (17-01-2005)
    “…Positron emission tomography (PET) in uro-oncology has been one of the slowest areas to develop. There are problems because of the excretion of tracer through…”
    Get full text
    Journal Article
  17. 17

    Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma by Hain, S F, O'Doherty, M J, Lucas, J D, Smith, M A

    Published in Nuclear medicine communications (01-09-1999)
    “…The aims of this study were to evaluate the uptake of fluorodeoxyglucose (FDG) in the stumps of patients who have had amputations for soft tissue sarcoma and…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Fluorodeoxyglucose PET in the initial staging of germ cell tumours by Hain, S F, O'Doherty, M J, Timothy, A R, Leslie, M D, Partridge, S E, Huddart, R A

    Published in European journal of nuclear medicine (01-05-2000)
    “…Testicular cancer is a rare tumour with the potential for cure at diagnosis. It is important, however, to identify those patients with metastases at…”
    Get more information
    Journal Article
  20. 20

    Soft-Tissue Uptake of Colonic Metastases by HAIN, S F, COOPER, R A, ARONEY, R S, KING, S, ROACH, P J

    Published in Clinical nuclear medicine (01-05-1999)
    “…Tc-99m MDP uptake into extraosseous malignant lesions with metastases to soft tissue has been well described. Tc-99m MDP uptake has been reported in primary…”
    Get full text
    Journal Article